Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yared Abate Getahun, Destaw Asfaw Ali, Bihonegn Wodajnew Taye & Yismaw Alemie Alemayehu. (2022) Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System. Veterinary Medicine: Research and Reports 13, pages 173-190.
Read now
Read now
Huiting Zhang, Yiting Zhang, Changhong Qiu, Wentian Zhu, Mingbo Wen & Xuejun Lao. (2021) Differentiation of human umbilical cord mesenchymal stem cells into parathyroid cells by editing the PTH gene with the CRISPR/Cas9 system. Biotechnology & Biotechnological Equipment 35:1, pages 1207-1213.
Read now
Read now
Ah Young Lee, Myung-Haing Cho & Sanghwa Kim. (2019) Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy. Expert Opinion on Drug Delivery 16:7, pages 757-772.
Read now
Read now
Articles from other publishers (79)
Milena Georgieva, Charilaos Xenodochidis & Natalia Krasteva. (2023) Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 184, pages 112334.
Crossref
Crossref
Shujun Zeng, Shuangyin Lei, Chao Qu, Yue Wang, Shuzhi Teng & Ping Huang. (2023) CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia. Human Genetics 142:12, pages 1677-1703.
Crossref
Crossref
Devin M. Stranford, Lacy M. Simons, Katherine E. Berman, Luyi Cheng, Beth N. DiBiase, Michelle E. Hung, Julius B. Lucks, Judd F. Hultquist & Joshua N. Leonard. (2023) Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells. Nature Biomedical Engineering.
Crossref
Crossref
Ghazaleh Behrouzian Fard, Mohammad Hossein Ahmadi, Mehran Gholamin, Razieh Amirfakhrian, Elahe Saberi Teimourian, Mohammad Ali Karimi & Mahdi Hosseini Bafghi. (2023) CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment. Biotechnology and Bioengineering.
Crossref
Crossref
Tuo Wei, Yehui Sun, Qiang Cheng, Sumanta Chatterjee, Zachary Traylor, Lindsay T. Johnson, Melissa L. Coquelin, Jialu Wang, Michael J. Torres, Xizhen Lian, Xu Wang, Yufen Xiao, Craig A. Hodges & Daniel J. Siegwart. (2023) Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models. Nature Communications 14:1.
Crossref
Crossref
Nihar Godbole, Alexander Quinn, Flavio Carrion, Emanuele Pelosi & Carlos Salomon. (2023) Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer. Seminars in Cancer Biology 96, pages 64-81.
Crossref
Crossref
Guillermo Aquino-Jarquin. (2023) Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems. Drug Discovery Today 28:11, pages 103793.
Crossref
Crossref
Andréa Witz, Julie Dardare, Aurélie Francois, Marie Husson, Marie Rouyer, Jessica Demange, Jean-Louis Merlin, Pauline Gilson & Alexandre Harlé. (2023) CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines. Scientific Reports 13:1.
Crossref
Crossref
Qisong Liu, Defeng Li, Xiaohua Pan & Yujie Liang. (2023) Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Ying-Qi Lin, Ke-Ke Feng, Jie-Ying Lu, Jing-Qing Le, Wu-Lin Li, Bing-Chen Zhang, Cheng-Lei Li, Xun-Huan Song, Ling-Wu Tong & Jing-Wei Shao. (2023) CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery. Journal of Controlled Release 361, pages 727-749.
Crossref
Crossref
Qing Rex Lyu, Shikuan Zhang, Zhe Zhang & Zhiyu Tang. (2023) Functional knockout of long non-coding RNAs with genome editing. Frontiers in Genetics 14.
Crossref
Crossref
Max Wichmann, Cecile L. Maire, Niklas Nuppenau, Moataz Habiballa, Almut Uhde, Katharina Kolbe, Tanja Schröder, Katrin Lamszus, Boris Fehse & Dawid Głów. (2023) Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPs. International Journal of Molecular Sciences 24:14, pages 11399.
Crossref
Crossref
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, Saurabh Sharma, Jasmin Monpara, Anisha A. D'Souza, Deepakkumar Mishra, Kamatham Pushpa Tryphena, Satoru Kawakita, Shahid Khan, Mohd Azhar, Dharmendra Kumar Khatri, Ketan Patel & Raghu Raj Singh Thakur. (2023) CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective. Advanced Science 10:19.
Crossref
Crossref
Dimitrios Stefanoudakis, Nikhita Kathuria-Prakash, Alexander W. Sun, Melissa Abel, Claire E. Drolen, Camille Ashbaugh, Shiliang Zhang, Gavin Hui, Yeganeh A. Tabatabaei, Yuliya Zektser, Lidia P. Lopez, Allan Pantuck & Alexandra Drakaki. (2023) The Potential Revolution of Cancer Treatment with CRISPR Technology. Cancers 15:6, pages 1813.
Crossref
Crossref
Jerry Vockley, Thomas Defay, Aaron J. Goldenberg & Amy M. Gaviglio. (2022) Scaling genetic resources: New paradigms for diagnosis and treatment of rare genetic disease. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 193:1, pages 77-86.
Crossref
Crossref
Maria Apostolidi & Vassiliki Stamatopoulou. (2023) Aberrant splicing in human cancer: An RNA structural code point of view. Frontiers in Pharmacology 14.
Crossref
Crossref
Manisha Singh, Vinayak Agarwal, Divya Jindal, Pranav Pancham, Shriya Agarwal, Shalini Mani, Raj Kumar Tiwari, Koushik Das, Badrah S. Alghamdi, Tukri S. Abujamel, Ghulam Md. Ashraf & Saurabh Kumar Jha. (2023) Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools. Diagnostics 13:3, pages 337.
Crossref
Crossref
Tianxiang Li, Yanyan Yang, Hongzhao Qi, Weigang Cui, Lin Zhang, Xiuxiu Fu, Xiangqin He, Meixin Liu, Pei-feng Li & Tao Yu. (2023) CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Brijesh Lohchania, Abisha Crystal Christopher, Porkizhi Arjunan, Gokulnath Mahalingam, Durga Kathirvelu, Aishwarya Prasannan, Vigneshwaran Venkatesan, Pankaj Taneja, Mohan Kumar KM, Saravanabhavan Thangavel & Srujan Marepally. (2023) Diosgenin enhances liposome-enabled nucleic acid delivery and CRISPR/Cas9-mediated gene editing by modulating endocytic pathways. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Neha Masarkar, Suman Kumar Ray, Pragati Raghuwanshi, Ashish K. Yadav & Sukhes Mukherjee. 2023. Hypoxia in Cancer: Significance and Impact on Cancer Therapy. Hypoxia in Cancer: Significance and Impact on Cancer Therapy
275
295
.
Zhifen Chen, Constanze Lehertshuber & Heribert Schunkert. 2023. Genome Editing in Cardiovascular and Metabolic Diseases. Genome Editing in Cardiovascular and Metabolic Diseases
139
156
.
Shiu-Jau Chen, Shao-Cheng Wang & Yuan-Chuan Chen. (2022) Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections. Tropical Medicine and Infectious Disease 7:12, pages 439.
Crossref
Crossref
Juan Lou, Bin Wang, Junwei Li, Peng Ni, Yuefei Jin, Shuaiyin Chen, Yuanlin Xi, Rongguang Zhang & Guangcai Duan. (2022) The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases. Molecular Biology Reports 49:12, pages 11301-11311.
Crossref
Crossref
Zaheer Ahmed & Rizwan Qaisar. (2022) Nanomedicine for Treating Muscle Dystrophies: Opportunities, Challenges, and Future Perspectives. International Journal of Molecular Sciences 23:19, pages 12039.
Crossref
Crossref
Jessica L. Childs-Disney, Xueyi Yang, Quentin M. R. Gibaut, Yuquan Tong, Robert T. Batey & Matthew D. Disney. (2022) Targeting RNA structures with small molecules. Nature Reviews Drug Discovery 21:10, pages 736-762.
Crossref
Crossref
Ankit Kumar Dubey, Vijai Kumar Gupta, Małgorzata Kujawska, Gorka Orive, Nam-Young Kim, Chen-zhong Li, Yogendra Kumar Mishra & Ajeet Kaushik. (2022) Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases. Journal of Nanostructure in Chemistry 12:5, pages 833-864.
Crossref
Crossref
Amit Khurana, Nilofer Sayed, Vishakha Singh, Isha Khurana, Prince Allawadhi, Pushkar Singh Rawat, Umashanker Navik, Sravan Kumar Pasumarthi, Kala Kumar Bharani & Ralf Weiskirchen. (2022) A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery. Journal of Cellular Biochemistry 123:10, pages 1674-1698.
Crossref
Crossref
Deepak Kumar Sahel, Mohd Salman, Mohd Azhar, Sangam Giri Goswami, Vivek Singh, Manu Dalela, Sujata Mohanty, Anupama Mittal, Sivaprakash Ramalingam & Deepak Chitkara. (2022) Cationic lipopolymeric nanoplexes containing the CRISPR/Cas9 ribonucleoprotein for genome surgery. Journal of Materials Chemistry B 10:37, pages 7634-7649.
Crossref
Crossref
Ying Hu, Bangjie Chen, Fan Yang, Yue Su, Dashuai Yang, Yan Yao, Shuxian Wang, Yincui Wu, Liangsong Tao & Tao Xu. (2022) Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection. Autoimmunity Reviews 21:9, pages 103155.
Crossref
Crossref
Pengcheng Liu, Fan Yang, Lizhi Zhang, Ying Hu, Bangjie Chen, Jianpeng Wang, Lei Su, Mingyue Wu & Wenjian Chen. (2022) Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Mohammad Enamul Hoque Kayesh, Md Abul Hashem, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2022) In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update. Frontiers in Microbiology 13.
Crossref
Crossref
Qian Xie, Shuangyin Lei, Chao Qu, Hao Wu, Yingru Liu, Ping Huang & Shuzhi Teng. (2022) Recent advances of CRISPR/Cas9 gene editing in the treatment of β-thalassemia. Chinese Science Bulletin 67:21, pages 2492-2508.
Crossref
Crossref
Alicia Davis, Kevin V. Morris & Galina Shevchenko. (2022) Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles. Molecular Therapy - Methods & Clinical Development 25, pages 158-169.
Crossref
Crossref
Xabier Osteikoetxea, Andreia Silva, Elisa Lázaro‐Ibáñez, Nikki Salmond, Olga Shatnyeva, Josia Stein, Jan Schick, Stephen Wren, Julia Lindgren, Mike Firth, Alexandra Madsen, Lorenz M. Mayr, Ross Overman, Rick Davies & Niek Dekker. (2022) Engineered Cas9 extracellular vesicles as a novel gene editing tool. Journal of Extracellular Vesicles 11:5.
Crossref
Crossref
Efren Chavez, Juanly Rodriguez, Yelena Drexler & Alessia Fornoni. (2022) Novel Therapies for Alport Syndrome. Frontiers in Medicine 9.
Crossref
Crossref
Liqing Lu, Dunkang Rao, Cuili Niu, Longhuai Cheng, Dejun Ma & Zhen Xi. (2022) Dibenzocyclooctyne‐Branched Primer Assembled Gene Nanovector and Its Potential Applications in Genome Editing. ChemBioChem 23:7.
Crossref
Crossref
O. Yu. Barkova, T. A. Larkina, A. A. Krutikova, E. A. Polteva, Yu. S. Shcherbakov, G. K. Peglivanyan & M. V. Pozovnikova. (2022) Innovative Approaches to Genome Editing in Chickens. Cytology and Genetics 56:2, pages 196-207.
Crossref
Crossref
Jonathan O’Keeffe Ahern, Irene Lara-Sáez, Dezhong Zhou, Rodolfo Murillas, Jose Bonafont, Ángeles Mencía, Marta García, Darío Manzanares, Jennifer Lynch, Ruth Foley, Qian Xu, A Sigen, Fernando Larcher & Wenxin Wang. (2021) Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system. Gene Therapy 29:3-4, pages 157-170.
Crossref
Crossref
Junhong Cai, Dongcai Wu, Yanbin Jin & Shan Bao. (2022) Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model. Journal of Healthcare Engineering 2022, pages 1-10.
Crossref
Crossref
Saleh Jamehdor, Sara Pajouhanfar, Sadaf Saba, Georges Uzan, Ali Teimoori & Sina Naserian. (2022) Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions. Cells 11:6, pages 999.
Crossref
Crossref
Yue Wang, Xiujue Zheng, Jun Liu, Qixian Chen & Yan Zhao. (2022) Convergent Arrangement of sgRNA and Cas9 in CRISPRsome for Transcellular Trafficking. ACS Materials Letters 4:3, pages 505-510.
Crossref
Crossref
Laura Taina-González & María de la Fuente. (2022) The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA. Pharmaceutics 14:2, pages 460.
Crossref
Crossref
Catherine Botto, Marco Rucli, Müge Defne Tekinsoy, Juliette Pulman, José-Alain Sahel & Deniz Dalkara. (2022) Early and late stage gene therapy interventions for inherited retinal degenerations. Progress in Retinal and Eye Research 86, pages 100975.
Crossref
Crossref
Ines Neundorf. 2022. Peptide and Peptidomimetic Therapeutics. Peptide and Peptidomimetic Therapeutics
235
254
.
Mouraya Hussein, Ben Berkhout & Elena Herrera-Carrillo. 2022. Biotechnologies for Gene Therapy. Biotechnologies for Gene Therapy
85
125
.
Saeedeh Ebrahimi, Mohsen Kalantari, Hamzeh Alipour, Kourosh Azizi, Qasem Asgari & Mohammad Saleh Bahreini. (2021) In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis. Microbial Pathogenesis 161, pages 105281.
Crossref
Crossref
Oleksandra Chabanovska, Anne-Marie Galow, Robert David & Heiko Lemcke. (2021) mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies. Advanced Drug Delivery Reviews 179, pages 114002.
Crossref
Crossref
Lingtong Zhi, Xin Su, Meichen Yin, Zikang Zhang, Hui Lu, Zhiyuan Niu, Changjiang Guo, Wuling Zhu & Xuan Zhang. (2021) Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges. Cellular Immunology 369, pages 104436.
Crossref
Crossref
Jian Lu, Jie Liu, Yuanqing Guo, Yuanjin Zhang, Yeye Xu & Xin Wang. (2021) CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B 11:10, pages 2973-2982.
Crossref
Crossref
Muhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour‐Alitappeh, Arash Sattari, Alexander Seifalian & Nader Bagheri. (2021) Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology. Biotechnology and Bioengineering 118:10, pages 3691-3705.
Crossref
Crossref
Xiao Xiao, Xiao Xiao, Ardo Nashalian, Alberto Libanori, Yunsheng Fang, Xiyao Li & Jun Chen. (2021) Triboelectric Nanogenerators for Self‐Powered Wound Healing. Advanced Healthcare Materials 10:20.
Crossref
Crossref
Ayelén Emilce López, María del Rosario Bauzá, Luis Cuniberti, Alberto José Crottogini, Fernanda Daniela Olea & Paola Locatelli. (2021) Gene Therapy: Targeting Cardiomyocyte Proliferation to Repopulate the Ischemic Heart. Journal of Cardiovascular Pharmacology 78:3, pages 346-360.
Crossref
Crossref
Qi Yan, Bang‐jie Chen, Shuang Hu, Shun‐li Qi, Liang‐yun Li, Jun‐fa Yang, Hong Zhou, Chen‐chen Yang, Li‐jian Chen & Jian Du. (2021) Emerging role of RNF2 in cancer: From bench to bedside. Journal of Cellular Physiology 236:8, pages 5453-5465.
Crossref
Crossref
Fangfang Wang, Ling Ling & Duonan Yu. (2021) MicroRNAs in β-thalassemia. The American Journal of the Medical Sciences 362:1, pages 5-12.
Crossref
Crossref
Lucia Carmela Cosenza, Jessica Gasparello, Nicola Romanini, Matteo Zurlo, Cristina Zuccato, Roberto Gambari & Alessia Finotti. (2021) Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients. Molecular Therapy - Methods & Clinical Development 21, pages 507-523.
Crossref
Crossref
Muhammad Sadeqi Nezhad, Meghdad Abdollahpour-Alitappeh, Behzad Rezaei, Mahboubeh Yazdanifar & Alexander Marcus Seifalian. (2021) Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products. Pharmaceutical Research 38:6, pages 931-945.
Crossref
Crossref
Munazza Ahmed, Grace Hope Daoud, Asmaa Mohamed & Rania Harati. (2021) New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer. Genes 12:5, pages 723.
Crossref
Crossref
Narmadhaa Siva, Sonal Gupta, Ayam Gupta, Jayendra Nath Shukla, Babita Malik & Nidhi Shukla. (2021) Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer. 3 Biotech 11:3.
Crossref
Crossref
Ilaria Andreana, Mathieu Repellin, Flavia Carton, David Kryza, Stéphanie Briançon, Bénédicte Chazaud, Rémi Mounier, Silvia Arpicco, Manuela Malatesta, Barbara Stella & Giovanna Lollo. (2021) Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. Pharmaceutics 13:2, pages 278.
Crossref
Crossref
Eun Roh, Anjani Darai, Jae Kyung, Hyemin Choi, Su Kwon, Basanta Bhujel, Kyoung Kim & Inbo Han. (2021) Genetic Therapy for Intervertebral Disc Degeneration. International Journal of Molecular Sciences 22:4, pages 1579.
Crossref
Crossref
Wei Lv, Tao Li, Shanshan Wang, Huihui Wang, Xuemei Li, Shubing Zhang, Lianzi Wang, Yuanhong Xu & Wei Wei. (2021) The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer. Technology in Cancer Research & Treatment 20, pages 153303382110452.
Crossref
Crossref
Shubhchintan Randhawa. 2021. Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy. Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy
129
163
.
Shubhchintan Randhawa & Shatakshi Sengar. 2021. Advances in CRISPR/Cas and Related Technologies. Advances in CRISPR/Cas and Related Technologies
1
62
.
Yuan-Chuan Chen. 2021. Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems Part A. Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems Part A
93
116
.
Paul Boucher, Xiaoxia Cui & David T. Curiel. (2020) Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors. Journal of Controlled Release 327, pages 788-800.
Crossref
Crossref
Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Valery Smirnov, Elena Volchkova, Alexander Lukashev & Vladimir Chulanov. (2020) Gene Editing by Extracellular Vesicles. International Journal of Molecular Sciences 21:19, pages 7362.
Crossref
Crossref
Ilayda Ates, Tanner Rathbone, Callie Stuart, P. Hudson Bridges & Renee N. Cottle. (2020) Delivery Approaches for Therapeutic Genome Editing and Challenges. Genes 11:10, pages 1113.
Crossref
Crossref
Shiu-Jau Chen, Shao-Cheng Wang & Yuan-Chuan Chen. (2020) Novel Antiviral Strategies in the Treatment of COVID-19: A Review. Microorganisms 8:9, pages 1259.
Crossref
Crossref
Reza Mohammadinejad, Ali Dehshahri, Hosseinali Sassan, Behzad Behnam, Milad Ashrafizadeh, Azadeh Samareh Gholami, Abbas Pardakhty & Ali Mandegary. (2020) Preparation of carbon dot as a potential CRISPR/Cas9 plasmid delivery system for lung cancer cells. Minerva Biotecnologica 32:3.
Crossref
Crossref
Reza Mohammadinejad, Alessio Biagioni, Ganesan Arunkumar, Rebecca Shapiro, Kun-Che Chang, Mohammed Sedeeq, Aftab Taiyab, Mohammad Hashemabadi, Abbas Pardakhty, Ali Mandegary, Jean-Paul Thiery, Amir Reza Aref & Iman Azimi. (2020) EMT signaling: potential contribution of CRISPR/Cas gene editing. Cellular and Molecular Life Sciences 77:14, pages 2701-2722.
Crossref
Crossref
Tuo Wei, Qiang Cheng, Yi-Li Min, Eric N. Olson & Daniel J. Siegwart. (2020) Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nature Communications 11:1.
Crossref
Crossref
Dong-Chu Yang, Alexander C. Eldredge, James C. Hickey, Hurik Muradyan & Zhibin Guan. (2020) Multivalent Peptide-Functionalized Bioreducible Polymers for Cellular Delivery of Various RNAs. Biomacromolecules 21:4, pages 1613-1624.
Crossref
Crossref
Sergio Daga, Francesco Donati, Katia Capitani, Susanna Croci, Rossella Tita, Annarita Giliberti, Floriana Valentino, Elisa Benetti, Chiara Fallerini, Francesca Niccheri, Margherita Baldassarri, Maria Antonietta Mencarelli, Elisa Frullanti, Simone Furini, Silvestro Giovanni Conticello, Alessandra Renieri & Anna Maria Pinto. (2019) New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells. European Journal of Human Genetics 28:4, pages 480-490.
Crossref
Crossref
Happy Panchasara, Shreya Patel & Vijai Singh. 2020. Genome Engineering via CRISPR-Cas9 System. Genome Engineering via CRISPR-Cas9 System
27
38
.
Jérôme Caron, Véronique Pène, Laia Tolosa, Maxime Villaret, Eléanor Luce, Angélique Fourrier, Jean-Marie Heslan, Samir Saheb, Eric Bruckert, María José Gómez-Lechón, Tuan Huy Nguyen, Arielle R. Rosenberg, Anne Weber & Anne Dubart-Kupperschmitt. (2019) Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection. Stem Cell Research & Therapy 10:1.
Crossref
Crossref
Piyush K. Jain, Justin H. Lo, Santosh Rananaware, Marco Downing, Apekshya Panda, Michelle Tai, Srivatsan Raghavan, Heather E. Fleming & Sangeeta N. Bhatia. (2019) Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes. Nanoscale 11:44, pages 21317-21323.
Crossref
Crossref
Toni Jauset & Marie-Eve Beaulieu. (2019) Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead. Current Opinion in Pharmacology 47, pages 133-140.
Crossref
Crossref
Piotr S. Kowalski, Arnab Rudra, Lei Miao & Daniel G. Anderson. (2019) Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Molecular Therapy 27:4, pages 710-728.
Crossref
Crossref
Kai Miao, Xin Zhang, Sek Man Su, Jianming Zeng, Zebin Huang, Un In Chan, Xiaoling Xu & Chu-Xia Deng. (2019) Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice. Journal of Biological Chemistry 294:4, pages 1142-1151.
Crossref
Crossref